4//SEC Filing
Luptakova Katarina 4
Accession 0001415889-25-000406
CIK 0001840233other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:15 PM ET
Size
9.3 KB
Accession
0001415889-25-000406
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-01−16,625→ 49,875 total→ Common Stock (16,625 underlying) - Exercise/Conversion
Common Stock
2025-01-01+16,625→ 16,625 total - Award
Stock Option (right to buy)
2025-01-01+200,000→ 200,000 totalExercise: $0.95Exp: 2035-12-31→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs) convert to stock on a one-for-one basis
- [F2]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
- [F3]The option was granted on January 1, 2025 and will vest in 48 equal monthly installments beginning on February 1, 2025 and continuing through January 1, 2029.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001991149
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:15 PM ET
- Size
- 9.3 KB